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Available online 13 April 2016Human umbilical cord (hUC) blood and tissue are non-invasive sources of potential stem/progenitor cells with
similar cell surface properties as bone marrow stromal cells (BMSCs). While they are limited in cord blood,
they may be more abundant in hUC. However, the hUC is an anatomically complex organ and the potential of
cells in various sites of the hUC has not been fully explored. We dissected the hUC into its discrete sites and iso-
lated hUC cells from the cord placenta junction (CPJ), cord tissue (CT), and Wharton's jelly (WJ). Isolated cells
displayed ﬁbroblastoid morphology, and expressed CD29, CD44, CD73, CD90, and CD105, and showed evidence
of differentiation into multiple lineages in vitro. They also expressed low levels of pluripotency genes, OCT4,
NANOG, SOX2 and KLF4. Passaging markedly affected cell proliferation with concomitant decreases in the ex-
pression of pluripotency and other markers, and an increase in chondrogenic markers. Microarray analysis fur-
ther revealed the differences in the gene expression of CPJ-, CT- and WJ-hUC cells. Five coding and ﬁve lncRNA
genes were differentially expressed in low vs. high passage hUC cells. Only MAEL was expressed at high levels
in both low and high passage CPJ-hUC cells. They displayed a greater proliferation limit and a higher degree of
multi-lineage differentiation in vitro and warrant further investigation to determine their full differentiation ca-
pacity, and therapeutic and regenerative medicine potential.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Proliferation1. Introduction
The successful isolation and culture of human embryonic stem cells
(ESCs)was a landmark achievement, which generated signiﬁcant interest
in the ﬁeld of stem cell biology. Pluripotent ESCs have the ability to self-
renew indeﬁnitely and to differentiate into ectoderm, mesoderm and en-
doderm (Carpenter et al., 2003; Hoffman and Carpenter, 2005;
Itskovitz-Eldor, 2002). While they are the most primitive, both ethical
and technical issues limit their therapeutic use (Fischbach and
Fischbach, 2004). Furthermore, their potential to form teratomas is also
amajor concern (Goldring et al., 2011). These challenges prompted stud-
ies to search for alternative sources of stem cells that do not pose moral,
ethical and safety dilemmas. Studies have shown the presence of adult
stem cells (ASCs) in various organs and body tissues. Bone marrow
(BM) has been a well-known source of ASCs, particularly hematopoietic
stem cells (HSCs), and to a lesser extent skeletal stem cells [SSCs, alsoSciences, Oakland University,
y).
. This is an open access article underknown as bone marrow-derived mesenchymal stem cells (Bianco and
Robey, 2015)] and endothelial progenitors. BM-derived HSCs have been
widely used for transplantation therapy to treat leukemia and blood dis-
orders. These cells have the ability to self-renew, are multipotent and
are able to differentiate into all blood lineages. Potential applications of
bone marrow stromal cells (BMSCs), which contain the subset of SSCs
(Robey et al., 2014), are limited because harvesting of BM involves an in-
vasive and painful procedure with possible donor site morbidity. In addi-
tion, donor age, genetics, and exposure to environmental stress could
cause a signiﬁcant reduction of biological activity in BMSCs (D'Ippolito
et al., 1999). Since a large number of cells are required for cell therapy
to regenerate tissues, or to treat most human diseases and dysfunctions,
it is imperative to search for new and robust sources of multipotent ASCs.
Recently, human umbilical cord (hUC) has been investigated as a
source of cells with stem/progenitor cell properties. hUC is a desirable
source of stem/progenitor cells as it is routinely discarded after delivery,
collection is non-invasive and an abundant number of cells are present
in cord tissue (Catacchio et al., 2013; Dominici et al., 2006; Weiss et al.,
2006). The differentiation potential and non-immunogenic nature of
hUC-derived cells could make them an ideal source for regenerativethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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derived from peri-natal sources such as amniotic ﬂuid, cord blood,
cord tissue and placenta are less likely to be altered due to aging or en-
vironmental stresses. While the presence of ﬁbroblastic cells with
BMSC-like characteristics in cord blood is limited, umbilical cord has
been found to be a promising source of potential stem/progenitor
cells. However, the cord is an anatomically complex organ and isolation
of potential stem/progenitor cells from its various sites has not been rig-
orously investigated.
In this study, we dissected the hUC into the cord-placenta junction
(CPJ), cord tissue (CT), and Wharton's jelly (WJ). Cells isolated from
these sites exhibited ﬁbroblastoid morphology, expressed markers
found on BMSCs and on other tissue-speciﬁc stem/progenitor cells. In
vitro, they displayed signs of multipotency. In addition, they expressed
pluripotency genes. CPJ-hUC cells showed higher proliferation capabili-
ties as comparedwith CT- andWJ-hUC cells. These ﬁndings suggest that
CPJ-hUC cells may have a potential use in tissue engineering and
regenerative medicine. Nevertheless, further studies are warranted to
fully explore the efﬁcacy and differentiation potential of CPJ-hUC cells.2. Materials and methods
2.1. Collection and processing of human umbilical cord samples
hUC samples (n = 50) were obtained from consented healthy do-
nors through the Beaumont Hospital BioBank, Royal Oak, MI under an
HIC (HIC #2012-101) approved protocol. The hUC samples were proc-
essed within 2–4 h of delivery. Brieﬂy, the sample was rinsed in
PBS several times until all the blood clots were removed. The hUC
was then dissected to separate CPJ, (the region between the cord
and placenta), CT (the outer layer of the cord), and WJ (the jelly-
like tissue within the cord and surrounding the blood vessels). The
CPJ, CT and WJ tissues were separately minced into approximately
1–2 mm pieces with the help of surgical and dissection tools, before
culturing the explants.2.2. Isolation of cells
The explants were cultured in 75 cm2 culture ﬂasks using culture
medium (CM) including DMEM with 4500 mg/ml glucose and 2 mM
L-glutamine (Invitrogen), supplemented with 10% FBS (Aleken Biologi-
cals). The medium was changed every 3 days until the cells started to
migrate from the explants (5–10 days after plating), after which me-
dium was changed every 1–2 days. When explant cells populated ap-
proximately 2/3 of the ﬂask, they were dissociated using TrypLE Select
(Invitrogen) and were considered as P0 cells. They were then passaged
(P1) in new culture ﬂasks at a concentration of 1 × 104 cells/cm2 for am-
pliﬁcation. When these cells reached 70% conﬂuency, they were har-
vested using TrypLE Select, cryopreserved, and sub-cultured for
further studies.2.3. Proliferation assay
Low passage (LP, P2–5) cells derived from CPJ, CT, and WJ were
seeded in 24-well plates at a concentration of 5 × 103 cells/well. After
predetermined time intervals (1–8 days), triplicate wells were treated
with 5 mg/ml MTT solution (Sigma) for 2 h in the dark at 37 °C in 5%
CO2 incubator. The reaction was then stopped and the formazan com-
plex was dissolved using 150 μl isopropanol with 10 μl of 0.1 N HCL on
a shaker for 15min in the dark. The optical density in eachwell was de-
termined at 570 nm using an EPOCH plate reader (BioTek). The back-
ground absorbance of blank wells was subtracted from all the
measured values.2.4. Cell cycle analysis
LP cells were subjected to cell cycle analysis. Brieﬂy, cells were
grown to 70% conﬂuency, tryspinized, and washed with PBS. Cells
(106) were ﬁxed with cold absolute ethanol and stored overnight at
4 °C, and then treated with 1 mg/ml RNase and PI staining solution
(Sigma) for 40 min in the incubator at 37 °C in the dark. The DNA con-
tent was assessed by a Nexcelom Cellometer (Nexcelom Bioscience
Lawrence) and results were analyzed using De Novo FCS Express 4
software.
2.5. Immunophenotyping
Flow cytometry was used to assess the cell surface marker proﬁle of
hUC cells. All experiments for FACS analysis were conducted with LP
and high passage (HP, NP15) cells. Brieﬂy, the cells were grown to 70%
conﬂuency, tryspinized, washed with PBS and pelleted. Cells (106)
were then stained directly with FITC-conjugated antibodies against:
CD34, CD44, CD45, CD90, or APC-conjugated antibodies against: CD29,
CD73, CD105 (Becton Dickinson). Cells were stained single or dual la-
beled and then analyzed on a FACS Canto II (Becton Dickinson) using
Diva Software (Beckton Dickinson).
2.6. Colony forming efﬁciency assay
Cellswere seeded at a concentration of 1.6 cells/cm2 in a petri dish in
triplicate and cultured using CM. After 10–14 days, cells were washed
with PBS, ﬁxed in 4% paraformaldehyde for 30 min, stained with 0.1%
crystal violet (Thermo Scientiﬁc) for 1 h, and then rinsed in tap water.
Colonies consisting of a minimal cell number of 50 cells were counted.
Data was recorded as total colony number per number of plated cells.
2.7. Lineage differentiation
LP cells were induced to differentiate along chondrogenic, osteo-
genic, and adipogenic lineages by culturing in speciﬁc differentiation
media. Chondrogenic differentiationwas induced inmonolayer and pel-
let cultures (obtained by centrifugation of 2.5 × 105 cells at 3000 RPM
for 10 min) using chondrogenic medium containing 20 ng TGFβ1,
10 ng insulin, 100 nM dexamethasone, and 100 μM ascorbic acid. After
3 weeks of culture, cells were stained with 1% toluidine blue and Peri-
odic acid–Schiff (PAS) reagent (Thermo Scientiﬁc) to detect extracellu-
lar matrix produced by chondrogenic derivatives of hUC cells.
Osteogenic differentiation was induced by using osteogenic medium
containing 0.1 μM dexamethasone, 10 μM β-glycerophosphate, and
50 μMascorbate-phosphate. After 3 weeks of culture, cells were stained
with alizarin red stain (Sigma) and von Kossa stain (Thermo Scientiﬁc)
to visualize calcium deposition. Adipogenic differentiation was induced
using adipogenic medium containing 0.5 μM isobutyl-methylxanthine,
1 μM dexamethasone, 10 μM insulin, and 200 μM indomethacin. After
3 weeks of culture, cells were stained with Oil Red O (Sigma) to deter-
mine the presence of lipid droplets. Cell cultures using CM served as
negative controls.
2.8. Sulfated glycosaminoglycans (sGAGs) assay
hUC cell pellets were incubated for 3 weeks in chondrogenic differ-
entiation medium and digested at 55 °C for 16 h with 125 μg/ml papain
(Sigma) in 100 mM sodium phosphate buffer containing 10 mM EDTA,
pH 6.5. Cell lysates were vortexed multiple times and cleared by centri-
fugation. sGAGs were determined by incubating the lysate with
dimethylmethylene blue (DMMB) dye in glycine/NaCl solution, pH 3.0
and the complex formed was quantiﬁed spectrophotometrically at ab-
sorbance 525 nm. Total sGAG content was determined by using the
chondroitin sulfate as a standard.
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Cellswere grownon coverslips, andﬁxedwith4%paraformaldehyde
(USB Products) for 10min at room temperature. Theywere thenperme-
abilized with 0.5% Triton X-100 (Sigma) and blocked in 2% bovine
serum albumin (Sigma) in PBS for 1 h. Then the cells were subjectedto primary antibody at 1:100 dilutions at 4 °C overnight followed by in-
cubation with secondary antibody at 1:200 dilutions at 37 °C for 1 h.
Fluorescently labeled cellswere counterstainedwith DAPI at 1:200dilu-
tions for 5 min at room temperature and mounted on to the slide. Fluo-
rescent images were captured using a confocal microscope (NIKON
Instruments Inc.). The primary and secondary antibodies used are listed
Fig. 2. Expression of pluripotency markers and cell cycle analysis of hUC cells. A–C: Protein expression of OCT4, NANOG, and LIN28, respectively, in hUC cells as determined by
immunocytostaining. Scale bars represent 100 μm (magniﬁcation: 10×) D and E: Histogram and bar graph representing various phases of cell cycle of CPJ-, CT-, and WJ-hUC cells,
respectively (*p ≤ 0.05). CT-hUC cells had a signiﬁcantly lower percentage of cells in G0/G1 phase as compared to CPJ- andWJ-hUC cells. All the experiments were performed in triplicate.
699N. Beeravolu et al. / Stem Cell Research 16 (2016) 696–711in Table S2. Non-immune immunoglobulins of the same isotype as the
primary antibody were used as negative controls.
2.10. Microarray analysis
LP and HP hUC cells were cultured using CM and harvested at 70%
conﬂuency. Cells were washed with PBS and pellets were stored atFig. 1.Derivation and characterization of potential stem/progenitor cells from human umbilical
(CT) andWharton's jelly (WJ). B: Phase contrast images of cells derived from CPJ, CT, andWJ dis
from CPJ, CT, and WJ displaying clonal growth of cells when replated. Photomicrographs are of
Scale bars represent 100 μm(magniﬁcation: 4×). D: Proliferation rate of stem cells as determine
WJ were similar but higher than cells derived from CT. E and F: Expression and graphical repr
respectively, as determined by ﬂow cytometry. Cells derived from all three sites (CPJ, CT and
HSC markers, CD34 and CD45 as well as HLA-DR. G: Expression of STRO-1, SUSD2, p75NTR
ACTIN and error bars represent the standard deviations of the triplicate measurements.−80 °C. RNA was isolated from frozen cell pellets using the E.Z.N.A.
Total RNA Kit I (Omega). Following the manufacturer's protocol, RNA
was puriﬁed using spin cartridge technology, quantiﬁed (Nanodrop
8000, Thermo Scientiﬁc), and then stored at−80 °C.
RNAwas then ampliﬁed and labeled using the GeneChip™WT PLUS
Reagent Kit (Affymetrix), which enables ampliﬁcation and target prep-
aration for whole transcriptome expression analysis. Ampliﬁcation wascord. A: Anatomical sites of the hUC; arteries, vein, cord placenta junction (CPJ), cord tissue
playing homogeneous ﬁbroblastoidmorphology. C: Phase contrast images of cells derived
LP (low passage) hUC cells stained with crystal violet displaying colony forming capacity.
d byusingMTT assay. (**p ≤ 0.01). The initial proliferation rate of cells derived fromCPJ and
esentation of data depicting percentages of cells expressing selected cell surface markers,
WJ), were positive for CD29, CD44, CD73, CD90, CD105 and HLA-ABC, and negative for
in cells derived from CPJ, CT, and WJ. Gene expression was normalized to GAPDH and
700 N. Beeravolu et al. / Stem Cell Research 16 (2016) 696–711performed with 500 ng of total RNA input following procedures de-
scribed in the WT PLUS Reagent Kit user manual. The ampliﬁed cDNA
was quantiﬁed, fragmented, and labeled in preparation for hybridiza-
tion to GeneChip™ Human Transcriptome 2.0 Arrays (Affymetrix)using 5.5 μg of ss-cDNA product following protocols outlined in the
aforementioned user manual. Washing, staining (GeneChip® Fluidics
Station 450, Affymetrix) and scanning (GeneChip® Scanner 3000,
Affymetrix) were performed following protocols outlined in the
701N. Beeravolu et al. / Stem Cell Research 16 (2016) 696–711GeneChip™ ExpressionWash, Stain, and ScanUserManual for Cartridge
Arrays. Analysis was conducted in Affymetrix Transcriptome Analysis
Console (version 1.0.0.234) and sub-network enrichment analysis
(SNEA), differential gene expression was determined by One-Way
Between-Subject ANOVA (Unpaired), with p-value b0.05 and a 2-fold
cutoff and p ≤ 0.05 and 1.5-fold cutoff respectively. Hierarchical cluster-
ingwas carried out using Partek® Genomics Suite 6.6 software (version
6.14.0923, Partek Inc.). Hierarchical clustering analysis was performed
using Euclidean distance as similarity measure and average linkage for
the agglomerative method. The accession numbers for the microarray
data reported in this paper are NCBI GEO: GSE72597 and GSE76295.
2.11. Quantitative reverse transcriptase polymerase chain reaction (qRT-
PCR) analysis
Cells were grown under appropriate conditions, harvested and used
to isolate total cellular mRNA using the GeneJET RNA puriﬁcation Kit
(Thermo Scientiﬁc), following the manufacturer's instructions. Total
RNA was puriﬁed by incubation with DNase at 37 °C for 30 min by
using a thermocycler (Bio-Rad). cDNA was synthesized by using iScript
kit (Bio-Rad). qRT-PCRwas performed by using Sso-AdvancedUniversal
SYBR Green Supermix Kit (Bio-Rad) on CFX96 Real-Time System (Bio-
Rad). A 10 μl reaction was used including 5 μl of Syber green, 3 μl of dis-
tilled H2O, 0.5 μl of forward primer, 0.5 μl of reverse primer, and 1 μl of
1:10 diluted cDNA. Each reaction was subjected to the following condi-
tions: 98 °C for 10 min, followed by 44 cycles of 98 °C for 30 s, 60 °C for
20 s, and 72 °C for 30 s in 96-well optical reaction plates (Bio-Rad). Ref-
erence genes, GAPDH and ACTIN, were used to normalize the ampliﬁca-
tion of the target genes. Each qRT-PCR analysis was performed in
triplicate. Primer sequences are listed in Table S3.
2.12. Statistical analysis
Data are presented as themean± SEM. Resultswith a p-value ≤0.05
were considered statistically signiﬁcant. All analyses were performed
using SPSS version 11.5 (SPSS Inc.).
3. Results
3.1. Derivation and characterization of hUC cells
In our preliminary studies with whole hUC, we isolated a heteroge-
neous population of colony forming cells. In fact, some reports had indi-
cated isolation of colony forming cells from CT and WJ (Ding et al.,
2015). This prompted us to dissect the hUC into identiﬁable anatomical
sites as depicted in Fig. 1A, and to isolate adherent cells from each part
separately. A signiﬁcant outgrowth of adherent cells was observed
within 3–4 days and 7–10 days in explants of CPJ and both CT and WJ,
respectively. Our attempts to isolate cells from the tissues enzymatically
had low yield and lacked reproducibility. Initially, isolated outgrowth
cells, irrespective of the anatomical sites, appeared to be ﬁbroblastoid
and expanded colonially when replated as shown in Fig. 1B and C, re-
spectively. In addition, the results of Colony Forming Efﬁciency (CFE) as-
says presented in Fig. 1C revealed variation in the hUC cells resulting
from passaging. CFE was determined to be 92, 59, and 80 colonies perFig. 3. Multi-lineage differentiation of hUC cells in vitro. A–F: Chondrogenic differentiation
chondrogenic medium for 3 weeks. The cell morphology as determined by phase contrast mi
(A and B, respectively). Histological sections of pellet cultures of chondrogenic derivatives st
glycoproteins (C and D, respectively). Photographic representation of pellet size of hUC cells a
cells cultured in chondrogenic medium as determined by DMMB assay and GAG contents we
of CPJ- and WJ-hUC cells were signiﬁcantly greater than CT-hUC cells. G–I: Osteogenic differe
cell morphology as determined by phase contrast microscopy, alizarin red and von Kossa stain
of osteogenic derivatives compared with the control hUC cells suggests bone mineralization b
cells grown for 3 weeks in the adipogenic medium. The cell morphology as determined by ph
K, respectively). Formation of lipid droplets is an indicative of adipogenic differentiation. Scale100 LP CPJ-, CT-, and WJ-hUC cells, respectively. LP CPJ- and WJ-hUC
cells displayed higher colony forming capacity than CT-hUC cells. The
results of a proliferation assay reported in Fig. 1D demonstrate that
CPJ-hUC cells had a signiﬁcantly higher growth rate when compared
with CT- and WJ-hUC cells.
Because the isolated cells from three sites of the hUCwere adherent,
and were able to form colonies, we wondered if they were similar to
stem/progenitor cells found in other connective tissues. It has been sug-
gested that cells loosely deﬁned as “MSCs” express certain cell surface
markers (Dominici et al., 2006; Robey et al., 2014), however, these
markers are not speciﬁc (Dominici et al., 2006; Robey et al., 2014). Nev-
ertheless, we subjected the isolated cells to immunophenotyping using
ﬂow cytometric analysis. The results reported in Fig. 1E and F show that
cells derived from all three sources expressed CD29, CD44, CD73, CD90,
and CD105, but not the hematopoietic speciﬁcmarkers, CD34 and CD45.
These cells were also found to be positive for major histocompatibility
class I, HLA-ABC and negative for class II, HLA-DR (also see Table S1).
Isolated P0 cells had 71–98% of cells expressing these markers; how-
ever, homogenous cell populations (95–99%) expressing these markers
was achieved upon further passaging (P1–P2). In addition, hUC cells
also expressed markers such as STRO-1, SUSD2 and p75NTR as shown
in Fig. 1G. Again, expression of these markers was highest in CPJ-hUC
cells. Interestingly, these markers have been recently used along with
others to identify BMSCs (Lin et al., 2011; Sivasubramaniyan et al.,
2013). Further immunocytochemical analysis of the isolated cells re-
vealed that they also expressed pluripotency genes, OCT4, NANOG,
and LIN28 as shown in Fig. 2A–C. Protein expression of these genes
was higher in both CPJ- and WJ-hUC cells than CT-hUC cells. However,
levels of these markers were much lower than in bona ﬁde pluripotent
ESCs (see Fig. S1).
The growth potential of the cells varied with the site from which
they originated, which prompted us to investigate the cell cycle of
these cells. A comparative analysis of the cell cycle of the cells derived
from all three sites is presented in Fig. 2D and E. Evidently; CPJ- and
WJ-hUC cells had similar GO/G1 and G2/M phases with a range of 75–
80% and 18–20% cells, respectively. Whereas, in case of CT-hUC cells,
G0/G1 phase had 10% lower but G2/M phase had 10% higher cells.
These results were consistent with the proliferation rate of the cells
from the three sites as stated above.
3.2. Multi-lineage differentiation potential of hUC cells
Based on their cell surface similarity to BMSCs, and their peri-natal
nature, the ability of hUC cells to differentiate towards mesenchymal
lineages (chondrogenic, osteogenic, and adipogenic cells) in vitro was
examined by culturing them in selective differentiation media. Mono-
layer cells incubated in chondrogenic medium for 3 weeks displayed al-
tered morphology as shown in Fig. 3A. Staining of the chondrogenic
derivatives of hUC cells with toluidine blue as depicted in Fig. 3B as
well as alcian blue (see Fig. S2) demonstrated production of GAG sug-
gesting that cells from all three sites differentiated into chondrogenic
lineage. Furthermore, histological sections of the pellet cultures also
stained positive for toluidine blue and PAS staining as shown in Fig. 3C
and D indicating that the differentiated derivatives produced proteogly-
cans and glycoproteins. In addition, the size of the pellets increasedof CPJ-, CT- and WJ-hUC cells. The cells were cultured as monolayers or as pellets in
croscopy and toluidine blue staining of monolayer chondrogenic derivatives of hUC cells
ained with toluidine blue and PAS displaying presence of glycosaminoglycan (GAG) and
fter culture in chondrogenic medium (E). Sulfated GAG (sGAG) content of pellets of hUC
re normalized to chondroitin sulfate as positive control (F). Pellet size and sGAG content
ntiation of CPJ-, CT- and WJ-hUC cells grown for 3 weeks in the osteogenic medium. The
ing of osteogenic derivatives of hUC cells (G–I, respectively). Signiﬁcantly higher staining
y production of calcium deposits. J–K: Adipogenic differentiation of CPJ-, CT- and WJ-hUC
ase contrast microscopy, and Oil Red O staining of adipogenic derivatives of hUC cells (J–
bars represent 100 μm (magniﬁcation: 4×).
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Fig. 3E indicating extracellularmatrix production, providing further ev-
idence of differentiation into chondrogenic lineage. The quantiﬁca-
tion of sGAGs shown in Fig. 3F indicates 2-fold increase in CPJ- andWJ-hUC cells derivatives relative to the control, compared to CT-
hUC cells. The variation in the pellet size and GAG content of cells
from the three sites incubated in chondrogenic medium could be at-
tributed to their differential chondrogenic potential, with CPJ- and
Fig. 4. Expression of cell speciﬁc proteins and genes in differentiated derivatives of hUC cells. The cells were cultured in respective differentiation media for 3 weeks and subjected to
analysis. A-F: Protein expression of SOX9, aggrecan (ACAN) and collagen 2 (COL 2), in chondrogenic derivatives of CPJ-, CT- and WJ-hUC cells in monolayer cultures (A–C, respectively)
and pellet cultures (D–F, respectively). G-H: Protein expression of collagen 1 (COL 1) and osteocalcin (OCN), in osteogenic derivatives of CPJ-, CT- and WJ-hUC cells, respectively, as
determined by immunocytochemical analysis. Scale bars represent 100 μm (magniﬁcation: 10×). I–K: Transcriptional levels of selected genes, for chondrogenic (SOX9, ACAN, and
COL2), osteogenic (COL1, RUNX2, OPN, and OCN) and adipogenic (CEBPβ, FABP4, and PPARγ) lineages, as determined by qRT-PCR analysis (**p ≤ 0.01 and *p ≤ 0.05). Gene expression
was normalized to GAPDH and ACTIN and error bars represent the standard deviations of the triplicate measurements.
703N. Beeravolu et al. / Stem Cell Research 16 (2016) 696–711WJ-hUC cells displaying better chondrogenic differentiation that CT-
hUC cells.
When hUC cells were cultured in osteogenic differentiationmedium
for 3 weeks, they displayed a cuboidal morphology as depicted in Fig.3G. The osteogenic derivatives from all three sites also stained positive
with alizarin red and von Kossa as shown in Fig. 3H and I, respectively,
indicating the presence of calcium phosphate deposits. Likewise, when
hUC cells were induced towards the adipogenic lineage, they produced
704 N. Beeravolu et al. / Stem Cell Research 16 (2016) 696–711lipid droplets thatwere positively stainedwith Oil RedO as presented in
Fig. 3J and K, respectively. Furthermore, we investigated the expression
of cell-speciﬁc proteins in the differentiated cells. The results ofimunocytostaining of chondrogenic derivatives of in hUC cells both
from monolayer and pellet culture depicted in Fig. 4A–C and D–F, re-
spectively, demonstrated the expression of chondrogenic markers,
705N. Beeravolu et al. / Stem Cell Research 16 (2016) 696–711SOX9, aggrecan (ACAN) and collagen 2 (COL2). Similarly,
immunocytostaining of osteogenic derivatives of hUC cells presented
in Fig. 4G and H, respectively, showed expression of characteristic oste-
ogenic markers, collagen 1 (COL1) and osteocalcin (OCN). qRT-PCR re-
sults of transcriptional analysis presented in Fig. 4I show increased
expression of chondrogenic genes, SOX9, ACAN and COL2 in the differ-
entiated derivatives. Highest expression of thesemarkers was observed
in chondrogenic derivatives of CPJ-hUC cells. Likewise transcriptional
analysis of osteogenic derivatives of hUC cells in Fig. 4J revealed in-
creased expression of osteogenic genes such as COL1, RUNX2, osteopon-
tin (OPN) and osteocalcin (OCN). Levels of expression of the osteogenic
marker, RUNX2, were greater in osteogenic derivatives of both CPJ- and
WJ-hUC cells than CT-hUC cells. Similar analysis of adipogenic deriva-
tives illustrated in Fig. 4K shows an increased expression of adipogenic
genes such as, CCAAT/enhancer-binding protein beta (CEBPβ), fatty
acid-binding protein (FABP4), and peroxisome proliferator-activated
receptor gamma (PPARγ) compared to control. Highest expression of
these markers was observed in derivatives of WJ-hUC cells than CPJ-
and CT-hUC cells. These in vitro results supported the notion that the
hUC-derived cells may have multi-lineage differentiation potential.3.3. Effect of passaging on the hUC cells
The growth rate of isolated hUC cells progressively decreased and
the cell size increased upon passaging as shown in Fig. 5A and B.
These changes were more pronounced in CT- and WJ-hUC cells. The
CFE alsomarkedly declined in all HP hUC cells (see Fig. S3). A signiﬁcant
drop in CFE can be seen in both CT- andWJ-hUC cells at P10 and in CPJ-
hUC cells at P20. The population doubling (PD) time as shown in Fig. 5C
was also affected by passaging. hUC cells were cultured until growth
ceased and PD time was measured for every passage, CPJ-hUC cells
showed signiﬁcantly shorter doubling time and greater number of PDs
as compared to CT- andWJ-hUC cells.WJ-hUC cells had the shortest cul-
ture time as cell growth arrested at P13. However, CT-hUC cells
displayed a longer PD time, but proliferation did not stop until P22.
The shortest PD time and longest culture periods were observed in the
case of CPJ-hUC cells, as proliferation stopped at P27. We also found
that passaging resulted in the loss of cell surface markers. FACs analysis
presented in Fig. 5D shows the overall loss of cell surface markers in HP
hUC cells. While the loss of CD90 wasmore pronounced than any other
marker in HP hUC cells from all three sites, other markers were less af-
fected in CPJ-hUC cells.
Further analysis of the hUC cells revealed that passaging also caused
rapid loss of pluripotency gene expression. A comparison of the expres-
sion of OCT4, SOX2, NANOG and KLF4 in both LP andHP hUC cells as de-
termined by qRT-PCR is presented in Fig. 5E. Although loss of all tested
markers was signiﬁcant, SOX2was completely lost in HP hUC cells from
all three sites and NANOG was lost in both HP CT- and WJ-hUC cells. It
should be noted, however, SOX2 and NANOGwere 4- and 6-fold higher
in LP CPJ-hUC cells compared to LP CT- and WJ-hUC cells, respectively.
Additionally, the results shown in Fig. 5F and G show expression of
markers indicative of the chondrogenic lineage without the cells being
cultured in chondrogenic medium as evidenced by the increased tran-
script levels of SOX9 and COL2, and protein expression of COL2, respec-
tively. All together these results indicate that CPJ-hUC cells had higher
growth and differentiation potential than CT- and WJ-hUC cells.Fig. 5. Comparison of morphology, proliferation, and expression of selected markers at low an
displaying increased cell size compared with LP hUC cells shown in Fig. 1. B: Cell size analysis
upon passaging. CPJ-hUC cells showed a higher number of population doublings than CT- and
LP and HP hUC cells. (*p ≤ 0.05). E and F: Transcription analysis of pluripotency genes, OC
determined by qRT-PCR. (**p ≤ 0.01 and *p ≤ 0.05). Gene expression was normalized to
measurements. G: Protein expression of COL2 in both LP and HP hUC cells as determined by im
higher expression of pluripotency makers. Expression of COL2 was increased in HP hUC cells c3.4. Microarray analysis of hUC cells
Since hUC cells derived from the three different sites displayed sig-
niﬁcant differences, we probed the global transcriptome of LP and HP
hUC cells. The Venn diagram of LP hUC cells transcriptome analysis
depicted in Fig. 6A shows that overall, 352 genes were differentially
expressed among hUC cells isolated from three sites of hUC. Out of
these, 133 genes were differentially expressed between hUC cells from
CPJ vs. CT (90 upregulated and 43 downregulated), 137 genes were dif-
ferentially expressed between hUC cells from CPJ vs. WJ (90 upregu-
lated and 47 downregulated), and 82 genes were differentially
expressed between hUC cells from CT vs. WJ (27 upregulated and 55
downregulated). There was only one overlapping gene, HOXD10,
which was common to all hUC cells.
When a similar global transcriptome analysis was performed with
HP hUC cells, unlike LP hUC cells, signiﬁcantly large numbers of genes
were found to be differentially expressed among CPJ-, CT-, and WJ-
hUC cells. The Venn diagram of HP hUC cells transcriptome analysis
depicted in Fig. 6B shows that overall 1821 genes were differentially
expressed among cells isolated from three sites of hUC. Out of these,
876 genes were differentially expressed between hUC cells from CPJ
vs. CT (434 upregulated and 442 downregulated), 302 genes were dif-
ferentially expressed between hUC cells from CPJ vs. WJ (211 upregu-
lated and 91 downregulated), and 643 genes were differentially
expressed genes between hUC cells from CT vs. WJ (319 upregulated
and 324 downregulated). Overall, in the global transcriptome analyses
of HP hUC cells, there were ten genes that were common in all the dif-
ferentially expressed genes found in hUC cells from three sites of the
hUC. Out of these ten genes, ﬁve genes were coding for FMOD, SULF1,
COL12A1, STMN2 and MAEL, and the remaining ﬁve were long-non-
coding RNA genes (lncRNA). Interestingly, among the ﬁve coding
genes, three genes (FMOD, COL12A1, and SULF1) belong to a family of
proteoglycans and an enzyme associated with extracellular matrix pro-
duction, and is expressed in chondrogenic lineage. Their expressionwas
highest in CT-hUC cells and lowest in CPJ-hUC cells. Expression of
STMN2, involved in neuronal growth associated protein, was found to
be highest in WJ-hUC cells and lowest in CPJ-hUC cells. Higher expres-
sion of these genes could be attributed to the lower rate of proliferation
in HP CT- andWJ-hUC cells. MAEL was the only gene that was differen-
tially expressed in both LP and HP hUC cells. In both the cases, its ex-
pression was highest in CPJ-hUC cells and lowest in WJ-hUC cells.
However, the signiﬁcance of these differences remains to be
investigated.
Because hUC cells from different sites of hUC had different proper-
ties, particularly relating to their proliferation and differentiation, we
further analyzed the microarray data to decipher the expression of
genes involved in these functions. Results of LP hUC cells analysis are il-
lustrated in Venn diagrams (Fig. 6C and D) and heatmaps (Fig. 6E and
F) for proliferation and differentiation gene categories, respectively.
The expanded heatmaps for detailed gene names are presented in
Figs. S5 and S6. It is clear that out of all the proliferation genes (n =
6971), 45 genes were differentially expressed, which overlapped in all
LP hUC cells. However, 9 genes were not differentially expressed in
hUC cells from CT vs. WJ. Likewise, among the differentiation genes
(n = 5873), 43 genes were expressed differentially and overlapped in
all LP hUC cells except 8 genes that were not differentially expressed
in hUC cells from CT vs. WJ. Interestingly, 7 of these genes (SULF1,d high passages of CPJ-, CT-, and WJ-hUC cells. A: Phase contrast images of HP hUC cells
of LP and HP hUC cells by using ﬂow cytometry. C: Doubling time of hUC cells increased
WJ-hUC cells. (**p ≤ 0.01). D: Comparison of expression of selected hUC cells markers in
T4, NANOG, KLF4 and SOX2 and chondrogenic genes, SOX9 and COL2 in hUC cells, as
GAPDH and ACTIN and error bars represent the standard deviations of the triplicate
munocytostaining. Scale bars represent 100 μm (magniﬁcation: 10×). CPJ-hUC cells had
ompared to LP hUC cells.
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found in the category of proliferation genes. Therefore, in both the pro-
liferation and differentiation categories, there were a total of 11 genes
that were not differentially expressed in CT vs. WJ. 4 of these 11 genes
(ANXA3, SHOX2 and DDX43 and MAEL) were distinctly expressed
higher, and 7 genes (SULF1, BCHE, SEMA3D, HOXA5, HOXA6, HOXD10,
PTPN3 and HOTAIRM1) were distinctly expressed lower in LP CPJ-hUC
cells. These results indicate that these 11 genes might play a role in
the different properties of CPJ-hUC cells. Differential expression of
these genes in hUC cells was conﬁrmed by qRT-PCR (Fig. 6G). However,
it remains to be determined whether the observed differences in hUC
cells properties from three sites of hUC can be attributed to the differen-
tial expression of these genes.
A similar analysis performed for the HP hUC cells is illustrated in Fig.
6J and K, which shows that out of all the proliferation genes, 349 differ-
entially expressed genes overlapped in all HP hUC cells except 26 genes
that were not differentially expressed in hUC cells from CT vs. WJ. Like-
wise, out of all the differentiation genes, 302 genes were differentially
expressed which overlapped in all hUC cells, but 22 genes were not dif-
ferentially expressed in hUC cells from CT vs. WJ. Taken together, there
were 14 genes (ENPP2, ITGA2, GPR158, AFAP1-AS1, SHOX2, ANPEP,
PDE5A, NR5A2, ARHGDIB, S100 A4, ABCG2, SESN3, ASPN, and RNF17)
that revealed higher expression in CPJ-hUC cells, and 5 genes (HOXA6,
RTN1, CPPED1, HOXA7 and MGST1) that were distinctly expressed
higher in WJ-hUC cells, which might play a role in the cessation of cell
proliferation. Interestingly, two differentiation genes (HOXA6 and
HOXD10) that were downregulated in LP CPJ-hUC cells were also
foundamong the13 downregulated genes inHPCPJ-hUC cells. However
only one of the two proliferation genes (ANXA3) that was upregulated
in LP CPJ-hUC cells was among the upregulated 18 genes in HP CPJ-
hUC cells. Only one gene (MEAL) was upregulated in both LP and HP
CPJ-hUC cells. The expanded heatmaps for detailed gene names are pre-
sented in Figs. S9 and S10.
Since hUC cells were affected by passaging, it was of interest to com-
pare the gene expression between the HP vs. LP hUC cells isolated from
all three sites of the hUC. The results shown in Fig. 7A indicate that 2174
genes were differentially expressed between HP vs. LP hUC cells from
CPJ (1287 upregulated and 887 downregulated), 2299 genes were dif-
ferentially expressed between HP vs. LP hUC cells from CT (1637 upreg-
ulated and 662 downregulated), and 1910 genes differentially
expressed were found between LP vs HP hUC cells fromWJ (1260 up-
regulated and 650 downregulated). A relatively large number of
genes, 942, were found to overlap. Therefore, we focused on genes in-
volved only in cell proliferation and differentiation. The results depicted
in Fig. 7B–E shows that therewere 482 and 370 proliferation and differ-
entiation genes, respectively, which were differentially expressed. The
expanded heatmaps for detailed gene names are presented in Figs. S8
and S9. 164 genes were upregulated and 318 genes were downregu-
lated within HP vs. LP hUC cells from CPJ. In HP vs. LP hUC cells from
CT, 169 genes were upregulated and 313 genes were downregulated.
In HP vs. LP hUC cells from WJ, 160 genes were upregulated and 322
genes were downregulated. Among the differentially expressed genes
between HP vs. LP hUC cells from CPJ, 126 genes were upregulated
and 244 genes were downregulated. In HP vs. LP hUC cells from CT,
133 genes were upregulated and 237 genes downregulated. In HP vs.
LP hUC cells from WJ, 115 genes were upregulated and 367 genes
were downregulated. Among the cell proliferation genes in HP vs. LPFig. 6. Comparative microarray analysis among CPJ-, CT-, and WJ-hUC cells. A–B: Venn diagram
diagrams and heatmaps displaying the differentially expressed genes involved in cell proliferati
presented in Figs. S5 and 6.G: Expression of selecteddifferentially expressed genes inCPJ-, CT-, a
expressed higher in CPJ- than in CT- and WJ-hUC cells (**p ≤ 0.01), whereas, two genes (HOXA
cells (**p ≤ 0.01). Gene expressionwas normalized to GAPDH and ACTIN and error bars represen
heatmaps displaying thedifferentially expressed genes involved in cell proliferation anddifferen
blue, respectively. Expanded heatmaps of HP hUC cells are presented in Figs. S7 and 8.hUC cells, 17–33 and 2–3 genes were differentially expressed by N5
fold and N10 fold, respectively. Genes showing greater than 10 fold up-
regulation were SLPI and RSAD2 in CPJ-hUC cells, ADAMTS5 in CT-hUC
cells, and IFIT2 andRSAD2 inWJ-hUC cells. In contrast, 10 fold downreg-
ulated genes were KIF20A and MKI67 in CT-hUC cells and KAL1 in WJ-
hUC cells. Similarly, N5 fold differentially expressed genes varied from
10 to 24 in HP vs. LP hUC cells of all three sites. A number of genes in-
volved in category of differentiation were N10 fold differentially
expressed in hUC cells including SLPI (upregulated) and MMP1 (down-
regulated) in HP CPJ-hUC cells,whereas ADAMTS5was upregulated and
MKI67was downregulated in HP CT-hUC cells, and RSAD2 was upregu-
lated and KAL1 was downregulated in HPWJ-hUC cells.
When the proliferation genes that were highly expressed in LP hUC
cellswere followed for their expression inHPhUC cells, 8 genes (EPHA3,
KDR, NCAM1, PTGFRN, PTGER2, SEMA3D, SULF1, and TFPI2), 5 genes
(DSP, EPHA3, NCAM1, PTGFRN, SEMA3D, and SULF1), and 4 genes
(DSP, KDR, PTERG2, and TFPI2) were found to be downregulated in HP
CPJ-hUC cells, CT-hUC cells, and WJ-hUC cells, respectively. Three
genes (KDR, PTERG2, and TFPI2) were found to display similar expres-
sion pattern in hUC cells from CPJ andWJ; however, their contributions
to the variation in properties of the hUC cells from these two sites re-
main to be established.
Similarly, the category of differentiation genes that had low expres-
sion in LP hUC cells and were upregulated in HP hUC cells included 6
genes (IFIH1, KDR, MAEL, SAMHD1, SP110, and STAT1), 2 genes
(CDH10 and PTGFRN), and 13 genes (DDX58, DSP, HOXA5, HOXA6,
HOXA7, HOXD10, IFIH1, IFIT3, PLSCR1, SAMHD1, SP110, STAT1 and
USP18) in hUC cells from CPJ, CT and WJ, respectively. However, only
3 genes (SAMHD1, SP110, and STAT1) had similar pattern of expression
in CPJ- and WJ-hUC cells. Again, their role in determining the variation
in properties of the hUC cells from these two sites remains to be
determined.
4. Discussion
One of themost important areas of interest in ASCs is the source and
efﬁcacy of isolation techniques to yield an adequate amount and homo-
geneous population of cells for tissue engineering and regenerative
medicine applications. Bone marrow is a well-recognized source of
ASCs (Catacchio et al., 2013) and contains HSCs, and SSCs/BMSCs
(Bianco and Robey, 2015; Robey et al., 2014). Isolation of potential
stem/progenitor cells from other adult tissues and organs with similar
cell surface characteristics as SSCs/BMSCs has also been reported (Cho
et al., 2015; Kim et al., 2015; Lee et al., 2013). However, most of these
sources require invasive procedures andmight have undergone genetic
changes due to environmental stresses and the aging process (Adams
et al., 2015; Burkhalter et al., 2015; Oh et al., 2014). To address these
concerns, putative stem/progenitor cells have been reported to be iso-
lated from noninvasive peri-natal sources such as amniotic ﬂuid and
umbilical cord blood (Fei et al., 2013; Odabas et al., 2014; Steigman
and Fauza, 2007; Wouters et al., 2007), but the yield is often low
(Erices et al., 2000; Goodwin et al., 2001; Rosada et al., 2003). Recently,
putative stem/progenitor cells have been also isolated from hUC
(Mennan et al., 2013). Stem/progenitor cells from different connective
tissues have been reported to display similar cell surface markers, par-
ticularly CD29, CD44, CD73, CD90, and CD105 (Dominici et al., 2006).
However, other characteristics of putative stem/progenitor cells, suchs displaying the comparative gene expression in LP and HP hUC cells. C–D and E–F: Venn
on and differentiation, respectively, in LP hUC cells. Expanded heatmaps of HP hUC cells are
ndWJ-hUC cells as determinedbyqRT-PCR. Three genes (MAEL, ANXA3 andDDX43),were
6 and HOXD10) had reduced expression in CPJ-hUC cells compared with CT- and WJ-hUC
t the standard deviations of the triplicatemeasurements. H–I and J–K: Venn diagrams and
tiation, respectively, inHP hUC cells. Up anddownregulated genes are displayed in red and
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vary widely depending upon the tissue source. For example, cells iso-
lated from older individuals or certain tissues have lower self-renewal
capacity compared with those isolated from younger individuals and
peri-natal sources (Escacena et al., 2015). Apparently, age of the source,
and character of the cellular or tissue niche are determining factors for
self-renewal and differentiation potential of various stem/progenitor
cell populations (Okolicsanyi et al., 2015). Therefore, a better under-
standing of the source and properties of tissue-speciﬁc stem/progenitor
cells could facilitate their therapeutic use.
Our attempts to isolate reproducibly homogenous population of
cells from hUC led us to dissect the cord into at least three distinct
sites, CPJ, CT, and WJ. Even though cells have been isolated from ex-
plants of CT, WJ and cord vein (Baksh et al., 2007; Chen et al., 2012;
Gonzalez et al., 2010; Han et al., 2013; Hendijani et al., 2014; Kadivar
et al., 2006; Conconi et al., 2011; Sarugaser et al., 2005; Romanov
et al., 2003), to our knowledge this is the ﬁrst report to show isolation
of cells from CPJ. In our study, all hUC samples (n = 50) dissected into
CPJ, CT andWJ yielded colony-forming cells with extensive proliferative
capacity, depending on the site fromwhich theywere derived. Cells iso-
lated from all three sites of hUC, had similar ﬁbroblastoid morphology
and expressed markers found on many tissue-speciﬁc stem/progenitor
cells such as, CD29, CD44, CD73, CD90 and CD105. They were also pos-
itive for HLA-ABC but not HLA-DR. These results were in agreement
with the previous reports (Dominici et al., 2006; Durnaoglu et al.,
2011; Mennan et al., 2013; Sarugaser et al., 2005; Weiss et al., 2006).
hUC cells were also found to express three markers (STRO-1, p75NTR,
SUSD2) expressed by BMSCs (Lin et al., 2011; Sivasubramaniyan et al.,
2013).
However, it is now understood that while tissue-speciﬁc stem/pro-
genitors do express CD29, CD44, CD73, CD90 and CD105, not all cells
that express these markers are stem/progenitor cells. Despite the ex-
pression of a number of SSC/BMSC-related genes, hUCs may be cord-
speciﬁc stem/progenitor cells, however, unequivocal identiﬁcation of
hUC cells warrant further investigation. The hUC cells derived from
CPJ, CT and WJ displayed multi-lineage properties when incubated in
speciﬁc differentiation media in vitro. The differentiated derivatives of
hUC cells displayed morphological and biochemical characteristics in-
cluding expression of markers for chondrogenic (ACAN, SOX9 and
COL2), osteogenic (COL1, OCN, OPN and RUNX2) and adipogenic
(CEBPβ, FABP4, and PPARγ) lineages in vitro.
hUC cells expressed pluripotent markers, OCT4, NANOG, KLF4 and
SOX2, but expression levels of all, except KLF4 were signiﬁcantly
lower than human ESCs (Fig. S3). Nevertheless, our results were in
agreement with a previous report showing expression of pluripotency
markers in cells from peri-natal sources (Nekanti et al., 2010). The re-
sults indicated that expression of these markers was site-dependent,
as highest levels of OCT4 and NANOG were found in CPJ-hUC cells.
These cells were also found to be themost proliferativewhen compared
to CT- and WJ-hUC cells. However, despite their common characteris-
tics, hUC cells derived fromdifferent sites of hUC differed in their colony
forming efﬁciency, regulation of cell cycle, and proliferation capabilities.
Furthermore, comparative analysis of the isolated hUC cells showed
that passaging gradually affected their properties. The cell size, CFE, and
growth rate was reduced in case of CT- and WJ-hUC cells upon passag-
ing compared to the CPJ-hUC cells. Passaging also affected the expres-
sion of pluripotent markers as well as certain cell surface markers.
Comparison of LP and HP hUC cells showed not only reduction in ex-
pression of pluripotency and cell surface markers, but increased the
cell size, suggesting that the cells are undergoing gradual changesFig. 7.Comparativemicroarray analysis between low and highpassage CPJ-, CT-, andWJ-hUC ce
and D-E: Venn diagrams and heatmaps showing differentially expressed categories of prolifera
red and blue, respectively. Expanded heatmaps are presented in Figs. S9 and 10.upon passaging. This hypothesis was strengthened by the fact that HP
hUC cells had higher expression of CD105, which is known to be
expressed in differentiating cells (Campbell and Pei, 2012; Habip
Akbulut et al., 2012; Jiang et al., 2010).
Previous studies (Cheng et al., 2011; Zaim et al., 2012) have suggested
that long-term passaging of stem/progenitor cells from different tissues
causes senescence and the patterns of senescence differed between tissue
sources and are age-dependent. Our analysis of HP hUC cells for negative
Gal staining (see Fig. S4) and lack of upregulation of senescence markers
(data not shown), such as p53 and p21 did not show that cells were un-
dergoing senescence. Our ﬁndings are similar to an earlier report (Hass
et al., 2011) which showed that the cells derived from neonatal tissues
displayed no sign of cellular senescence over long-term culture. Never-
theless, additional studies on the type and cause of growth arrest in
these cells should help develop long-term culturing techniques.
Further analysis of HP hUC cells showed that they expressed ele-
vated levels of chondrogenicmarkers such as SOX9 andCOL2, indicating
that they were undergoing differentiation by expressing speciﬁc pro-
teins found in chondrocytes. These ﬁndings were consistent with the
microarray analysis showing the increased expression of COL12A1 in
HP hUC cells. In fact, COL12A1 is reported to be associated with the
COL2 and COL1 in the production of the extracellular matrix suggesting
that HP hUC cells were undergoing chondrogenic differentiation
(Dharmavaram et al., 1998; Gregory et al., 2001; Narcisi et al., 2015;
Taylor et al., 2015).
In addition, the genome wide transcriptome analysis also revealed
that therewere various genes involved in cell proliferation and differen-
tiation that were differentially expressed between the hUC cells derived
from different sites of the same hUC. Out of these, two genes (ANXA3
and DDX43) were expressed at signiﬁcantly higher levels in CPJ- com-
pared to CT- andWJ-hUC cells. These genes have been extensively stud-
ied as biomarkers in the prognosis of various kinds of cancer cell lines
(Ambrosini et al., 2014; Zhai et al., 2014). The upregulation of these
genes correlates with increased cell proliferation and self-renewal. In
addition, two genes (HOXA6 and HOXD10) were expressed at lower
levels in CPJ- compared with CT- and WJ-hUC cells. Both of these
genes have been implicated in the regulation of cell differentiation
(Osborne et al., 1998; Walters et al., 1997). Their lower expression
could be responsible for longer-term proliferation as observed in case
of CPJ-hUC cells. Interestingly, one gene (MAEL) was found to be
expressed at high levels in CPJ-hUC cells. MEAL has been reported to
have an essential role in spermatogenesis and transposon repression
(Yuan et al., 2014). Investigation of the potential role of MAEL in hUC
cells should be of interest.
Overall, ten genes, ﬁve of which are coding genes (FMOD, SULF1,
COL12A1, STMN2 and MAEL), and ﬁve long-non-coding RNA (lncRNA)
genes, were differentially expressed in hUC cells. lncRNAs are non-
protein coding transcripts longer than 200 nucleotides. They have
been implicated in the regulation of gene expression at epigenetic, tran-
scriptional and post transcriptional levels (Cao, 2014). Recently, their
role inmany biological processes, including pluripotency and differenti-
ation, has been recognized. Further investigation of the lncRNAs found
in our study may shed light as to their speciﬁc functions in hUC cells.
While these results are based on in vitro studies, further in vivo stud-
ies arewarranted for amore explicit proof for the ability of hUC cells ex-
hibit multipotency and the ability to self-renew as would be
demonstrated by serial transplantation assays.
In conclusion, our study provided a direct and relevant comparison
of hUC cells isolated from the three different sites of hUC, namely the
CPJ, CT, and WJ. The results clearly showed that CPJ is a distinct hUClls. A: Venndiagramdisplaying the differentially expressed genes in LP vs. HP hUC cells. B-C
tion and differentiation genes, respectively. Up and downregulated genes are displayed in
710 N. Beeravolu et al. / Stem Cell Research 16 (2016) 696–711region with higher proliferation and differentiation potential, which
could provide a promising source of stem/progenitor cells tissue
engineering and regenerative medicine.
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